Millennium Management LLC Buys 144,531 Shares of Teleflex Incorporated $TFX

Key Points

• Millennium Management LLC increased its stake in Teleflex Incorporated by 57.8%, owning 394,633 shares valued at approximately $54.5 million as of its latest SEC filing.
• Teleflex reported a quarterly earnings per share of $3.73, beating expectations, and set its FY 2025 guidance at a range of $13.900 to $14.300 EPS.
• The firm declared a quarterly dividend of $0.34, resulting in an annualized yield of 1.0% and a payout ratio of 32.00%.

Millennium Management LLC grew its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 57.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 394,633 shares of the medical technology company's stock after acquiring an additional 144,531 shares during the quarter. Millennium Management LLC owned about 0.89% of Teleflex worth $54,534,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of TFX. Ameriprise Financial Inc. boosted its position in Teleflex by 62.4% in the fourth quarter. Ameriprise Financial Inc. now owns 23,660 shares of the medical technology company's stock worth $4,211,000 after purchasing an additional 9,094 shares during the last quarter. Captrust Financial Advisors raised its stake in shares of Teleflex by 4.2% during the 4th quarter. Captrust Financial Advisors now owns 4,217 shares of the medical technology company's stock valued at $750,000 after purchasing an additional 169 shares during the period. Crestline Management LP bought a new stake in shares of Teleflex during the 4th quarter valued at $330,000. Deutsche Bank AG raised its stake in shares of Teleflex by 62.5% during the 4th quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock valued at $72,461,000 after purchasing an additional 156,524 shares during the period. Finally, D. E. Shaw & Co. Inc. raised its stake in shares of Teleflex by 232.9% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 146,944 shares of the medical technology company's stock valued at $26,153,000 after purchasing an additional 102,804 shares during the period. Institutional investors own 95.62% of the company's stock.

Insider Buying and Selling

In related news, Director Gretchen R. Haggerty acquired 500 shares of Teleflex stock in a transaction that occurred on Wednesday, August 6th. The stock was bought at an average price of $114.75 per share, with a total value of $57,375.00. Following the transaction, the director directly owned 6,305 shares in the company, valued at approximately $723,498.75. This represents a 8.61% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Liam Kelly acquired 1,500 shares of Teleflex stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average cost of $115.07 per share, with a total value of $172,605.00. Following the transaction, the chief executive officer owned 45,267 shares in the company, valued at $5,208,873.69. This represents a 3.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 5,500 shares of company stock worth $633,590 over the last quarter. Company insiders own 1.40% of the company's stock.

Teleflex Trading Up 0.1%

NYSE TFX traded up $0.07 on Wednesday, hitting $130.30. The company's stock had a trading volume of 858,756 shares, compared to its average volume of 542,622. The firm has a market cap of $5.76 billion, a P/E ratio of 30.66, a PEG ratio of 1.82 and a beta of 1.08. Teleflex Incorporated has a 52-week low of $108.90 and a 52-week high of $249.90. The company's 50-day simple moving average is $120.50 and its 200 day simple moving average is $127.07. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The firm had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the company earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, August 15th. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on TFX shares. Royal Bank Of Canada upped their target price on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research note on Friday, August 1st. Wells Fargo & Company decreased their target price on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Wall Street Zen upgraded Teleflex from a "buy" rating to a "strong-buy" rating in a research note on Sunday. Finally, Mizuho upped their target price on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.